No abstract available.
Animals ; Electric Stimulation* ; Rats* ; Skin*

No abstract available.
Animals ; Atrophy* ; Electric Stimulation* ; Muscle, Skeletal* ; Rats* ; Sciatic Nerve*

No abstract available.
Animals ; Fibroblasts* ; Fluorouracil* ; Rats*

No abstract available.
Masticatory Muscles* ; Trismus*

No abstract available.
Lung Neoplasms* ; Lung*

No abstract available.
Coronary Artery Bypass* ; Saphenous Vein*

No abstract available.
Pulmonary Aspergillosis*

No abstract available.
Sinusitis*

BACKGROUND: Recently authentic human growth hormone(hGH) has produced in the E coli K-12, W3110 by recombinant DNA tecbnology in Korea In this paper, the clinical efficacy and immunogenicity of this GH was shdied in 38 children with growth hormone deficiency during therapy of 1 year. METHODS: The subjects of this study were aged 4.9-13.9 years, diagnosed by failure of plasma GH to respond to insulin-induced hypoglycemia, arginine and/or L-dopa loading and height below -2 standard deviation of mean for their chronological age. Each patient received GH 0.5-0.7IU/kg/week subcutaneously in 6-7 divided doses. During treatment, vital signs, height, body weight and bone age were checked every 3 months. Complete blood count, urinalysis, blood chemistry and thyroid hormone were checked before and every 6 months. The measurement of serum IGF-1 level and antibody against hGH were performed before and every 6 months during therapy of I year. RESULT: The height velocities significantly increased from 3.3 +/- 1.5cm/year to 10.1 +/- 2.5 and 9.0 +/- 1.8cm/year at 6 and 12 months of therapy, respectively. The height standard deviation score for chronological age were significantly improved from -2.141.50 to -1.74 +/- 1.43 and -1.54 +/- 1.38 at 6 and 12 months of therapy with increasing ratio of bone age to chronological age from 0.72 +/- 0.15 at pretreatment to 0.76 +/- 0.15 at 6 month, 0.79 +/- 0.16 at 12 month of therapy. The plasma IGF-1 level significantly increased during treatment. One of 36 patients(2.8%) showed positive antibody against hGH after 1 year of treatment. During therapy of 1 year, unwanted and remarkable clinical side effect were not observed in all subjects. CONCLUSION: These results indicate that this E. coli derived authentic recombinant growth hormone is very effective in stimulating linear growth in children with growth hormone deficiency.
Arginine ; Blood Cell Count ; Body Height ; Chemistry ; Child* ; DNA, Recombinant ; Escherichia coli ; Growth Hormone* ; Human Growth Hormone ; Humans* ; Hypoglycemia ; Insulin-Like Growth Factor I ; Korea ; Levodopa ; Plasma ; Thyroid Gland ; Urinalysis ; Vital Signs

When an axon is severed, degenerative changes occur in the injured neuron as well as in those with which it has synaptic connections through transneuronal degeneration. Transneuronal degeneration includes all atrophic or degenerative changes that occur in nerve cells following the disappearance of their efferent (retrograde transneuronal degeneration) or afferent (anterograde transneuronal degeneration) connections. Previous studies have shown that transneuronal degeneration may occur in the neurons of various central nervous system following injury to their peripheral nerve. However, the effect of transneuronal degeneration on the neurons which are related with damaged neurons functionally and structurally is not elucidated yet. Denervation due to axonal degeneration or dysfunction of nerve cell bodies leads to physiological and biochemical changes in the skeletal muscles, and the extent of neuronal degeneration can be assessed through the muscle atrophy and the changes in muscle fiber type density. In order to identify the effect of transneuronal degeneration on the adjacent peripheral nerves as well as muscles, the left femoral nerve of Sprague -Dawley rats was transected, and changes in their spinal cords and hindlimb muscles were analysed morphologically and histochemically. The results obtained are as follows : 1. the motor neurons of ipsilateral anterior horn of femoral nerve transected rats showed reduction in size and degenerative features such as shriven shape and nucleus moved to periphery of the cell body. 2. All three muscle fiber types of rectus femoris and adductor longus were reduced in muscle fiber size, but no such changes were observed in semitendinosus. 3. In rectus femoris and adductor longus, type IIa muscle fiber was increased in number and the number of type IIb fiber was reduced, whereas no change was observed in all three muscle fiber types of semitendinosus. These findings indicate that damaged neurons following peripheral nerve injury can affect other adjacent neurons through transneuronal degeneration and cause the denervative changes in the muscles innervated by those adjacent neurons concomitantly, and such effects are only observed in the same spinal cord level.
Animals ; Axons ; Central Nervous System ; Denervation ; Femoral Nerve ; Hindlimb ; Horns ; Motor Neurons ; Muscle, Skeletal ; Muscles ; Muscular Atrophy ; Neurons ; Peripheral Nerve Injuries* ; Peripheral Nerves* ; Quadriceps Muscle ; Rats* ; Spinal Cord